SEC Form 4 · accession 0001179110-18-012105
Kala Pharmaceuticals, Inc. · KALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory Grunberg
Director
Period of report
Oct 5, 2018
Accepted (ET)
Oct 9, 2018 · 4:46 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001479419
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 5, 2018 | P | 606,060 | $8.25 | A | 2,877,006 | I | By Longitude Venture Partners II, L.P. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares are held by Longitude Venture Partners II, L.P. The Reporting Person is a member of Longitude Capital Partners II, LLC, the general partner of Longitude Venture Partners II, L.P., and may be deemed to share voting and investment power over these shares. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.